GlassScriptPhysician profile
Lai Chow Kok
NPI 1366414344
$73,758.39
in general payments reported to CMS, 2019-2025
31 companies · $64K in 2025
The $64K reported for 2025 was more than what 96% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,254 · 2020: $1,393 · 2021: $1,757 · 2022: $1,412 · 2023: $1,472 · 2024: $2,921 · 2025: $64K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $47K · Travel and Lodging: $16K · Food and Beverage: $4,653.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $47,250.00 |
| Travel and Lodging | $16,038.97 |
| Food and Beverage | $4,652.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $65,867.06 | 2021-2025 | Pulseselect, Affera Mapping System, Cardioinsight |
| Novartis Pharmaceuticals Corporation | $986.32 | 2019-2025 | |
| Abbott Laboratories | $796.02 | 2019-2025 | Ensite, Ensite Precision, Assurity |
| Astrazeneca Pharmaceuticals LP | $765.36 | 2019-2024 | Brilinta, Lokelma, Farxiga |
| Boston Scientific Corporation | $664.93 | 2019-2025 | Watchman Access System, Farapulse, Rhythmia Mapping System |
| Amgen INC. | $596.03 | 2019-2025 | Repatha, Repatha |
| E.R. Squibb & Sons, L.L.C. | $564.13 | 2019-2025 | Camzyos, Eliquis |
| Cardiva Medical, INC. | $481.12 | 2021-2025 | Optowire, Cardiva Vascade Mvp Vvcs 6-12f, Savvywire |
| Medtronic Vascular, INC. | $429.13 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $419.83 | 2019-2023 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $365.77 | 2019-2023 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $356.58 | 2019-2025 | Lifevest |
| Biosense Webster, INC. | $286.26 | 2019-2025 | Carto 3, Nuvision Ice Catheter, Qdot Micro |
| Biotronik INC. | $180.97 | 2019-2025 | Acticor 7 Vr-T Dx, Biomonitor |
| Atricure, INC. | $178.44 | 2023-2025 | Epi-Sense Guided Coagulation System With Visitrax |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $167.76 | 2024 | (Ck4) Mcot, (Cm9) Amb Mon & Diag Und |
| Merck Sharp & Dohme LLC | $123.31 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $75.49 | 2019 | |
| Abiomed | $56.80 | 2021 | |
| Vital Connect, INC | $53.12 | 2023-2024 | Vitalpatch Rtm |
| Pfizer INC. | $49.78 | 2019-2021 | |
| Vektor Medical INC. | $44.23 | 2024 | Vmap |
| Bayer Healthcare Pharmaceuticals INC. | $40.67 | 2023 | |
| Novo Nordisk INC | $33.91 | 2023-2024 | Ozempic, Rybelsus |
| Elutia, INC. | $33.61 | 2024-2025 | Ecm Patch,Pouch |
| Kiniksa Pharmaceuticals, LTD. | $30.55 | 2023 | Arcalyst |
| Recor Medical INC | $28.98 | 2025 | Paradise Ultrasound Renal Denervation System |
| Davol INC. | $26.77 | 2025 | Arista |
| Siemens Medical Solutions USA, INC. | $24.00 | 2023 | Artis Zee Multi-Purpose |
| Impulse Dynamics (USA) INC. | $16.65 | 2022 | |
| Zoll Respicardia, INC. | $14.81 | 2023 | Remede System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lai Chow Kok listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.